Clinical trial
Minimal Invasive Surfactant Administration to Treat Neonatal Respiratory Distress Syndrome: a Multicenter Clinical Study in China
NCT04077333 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Minimal Invasive Surfactant Administration to Treat Neonatal Respiratory Distress Syndrome: a Multicenter Clinical Study in China
- Lead sponsor
- Peking University Third Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 1, 2017
- Completion date
- March 30, 2019
- Enrollment
- 237 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bronchopulmonary dysplasia, intraventricular hemorrhage, necrotizing enterocolitis, patent ductus arteriosus, periventricular leukomalacia